Ken Harvey wrote:
The long-apprehended 20% cut in the PBS price of simvastatin is set to bite next month, dragging numerous pravastatin brands down with it and earning Ranbaxy the ire of fellow generics makers and pharmacists alike.
When's it OTC, Ken?
David _______________________________________________ Gpcg_talk mailing list [email protected] http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk
